Clark Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.3K Hold
717
0.02% 128
2026
Q1
$43.5K Hold
717
0.03% 112
2025
Q4
$38.7K Hold
717
0.02% 119
2025
Q3
$38.7K Buy
717
+616
+610% +$28.8K 0.02% 119
2025
Q2
$4.67K Sell
101
-6
-6% -$295 ﹤0.01% 292
2025
Q1
$6.53K Sell
107
-33
-24% -$1.92K ﹤0.01% 248
2024
Q4
$7.92K Buy
+140
New +$7.82K 0.01% 190

Other funds holding BMY

Clark Wealth Partners's BMY Position: Q2 2026 in Review

Clark Wealth Partners held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 717 shares worth $41.3K. The position accounts for 0.02% of the portfolio, ranked #128.

Clark Wealth Partners first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $43.5K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Clark Wealth Partners held 717 shares of Bristol-Myers Squibb worth $41.3K as of Q2 2026.
  • Clark Wealth Partners left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.02% of Clark Wealth Partners's portfolio in Q2 2026, its #128 holding.
  • Clark Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Clark Wealth Partners's Bristol-Myers Squibb position peaked at $43.5K in Q1 2026.
  • 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.